HAT in Eye Complications of Behcet's Disease
NCT00001865
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
26
Enrollment
NIH
Sponsor class
Conditions
Behcet's Syndrome
Retinal Disease
Uveitis
Interventions
DRUG:
Daclizumab
Sponsor
National Eye Institute (NEI)